Molecular evolution of breast cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pathology

• Publication date

  2005-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1691PMID 15641021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Columnar cell lesions of the breast

  2005influential reference
• Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1

  2004cited by this paper
• Different mechanisms of chromosome 16 loss of heterozygosity in well‐ versus poorly differentiated ductal breast cancer

  2004cited by this paper
• Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes

  2004cited by this paper
• Distinct Genetic and Epigenetic Changes in Medullary Breast Cancer

  2003cited by this paper
• The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ

  2003influential reference
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH.

  2003cited by this paper
• Frequent E-cadherin Gene Inactivation by Loss of Heterozygosity in Pleomorphic Lobular Carcinoma of the Breast

  2003cited by this paper
• Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast

  2003cited by this paper
• The role of E‐cadherin in low‐grade ductal breast tumourigenesis

  2003cited by this paper
• Molecular Evolutionary Patterns in Breast Cancer

  2003influential reference
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003influential reference
• DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors.

  2003cited by this paper
• Columnar Cell Lesions of the Breast

  2003cited by this paper
• In lymph node‐negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor

  2003cited by this paper
• Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.

  2003cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• In-situ lobular neoplasia: time for an awakening.

  2003cited by this paper
• The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions

  2003influential reference
• Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis

  2002cited by this paper
• Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.

  2002cited by this paper
• Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis

  2002cited by this paper
• SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways

  2002cited by this paper
• Genetic pathways in the evolution of breast ductal carcinoma in situ

  2002cited by this paper
• Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases

  2002cited by this paper
• Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas

  2002cited by this paper
• E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?

  2001cited by this paper
• Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

  2001influential reference
• Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization

  2001cited by this paper
• CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation

  2001cited by this paper
• Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001influential reference
• Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high‐molecular‐weight cytokeratin expression patterns

  2001influential reference
• Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast

  2001cited by this paper
• Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.

  2001cited by this paper
• Genomic alterations in tubular breast carcinomas.

  2001cited by this paper
• Loss of chromosome 16q in lobular carcinoma in situ.

  2001cited by this paper
• Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.

  2001cited by this paper
• Heterogeneous Chromosomal Aberrations in Intraductal Breast Lesions Adjacent to Invasive Carcinoma

  2000cited by this paper
• Patterns of chromosomal imbalances in invasive breast cancer

  2000cited by this paper
• Genetic abnormalities in mammary ductal intraepithelial neoplasia‐flat type (“clinging ductal carcinoma in situ”)

  2000cited by this paper
• Pleomorphic Lobular Carcinoma: Morphology, Immunohistochemistry, and Molecular Analysis

  2000cited by this paper
• Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast

  2000cited by this paper
• Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.

  2000cited by this paper
• Genetic changes in breast cancer detected by comparative genomic hybridisation

  2000cited by this paper
• Comparative Genomic Hybridization Analysis of Myoepithelial Carcinoma of the Breast

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.

  2000cited by this paper
• Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways

  1999cited by this paper
• Genetic alterations in ‘normal’ luminal and myoepithelial cells of the breast

  1999cited by this paper
• The transition from hyperplasia to invasive carcinoma of the breast

  1999cited by this paper
• Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology

  1999cited by this paper
• LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.

  1999cited by this paper
• 20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast

  1999cited by this paper
• Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

  1999influential reference
• Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

  1999cited by this paper
• Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

  1998cited by this paper
• Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

  1998cited by this paper
• Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.

  1998cited by this paper
• Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.

  1998cited by this paper
• Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications.

  1998cited by this paper
• Genetic alterations in lobular breast cancer by comparative genomic hybridization

  1997cited by this paper
• Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.

  1996cited by this paper
• Laser Capture Microdissection

  1996cited by this paper
• Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

  1995cited by this paper
• Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.

  1995cited by this paper
• Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.

  1992cited by this paper
• Cytogenetic analysis by chromosome painting using dop‐pcr amplified flow‐sorted chromosomes

  1992cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper

• Glycan and glycoprotein signatures in tumor-induced liver alterations in a murine breast cancer model

  2026cites this paper
• Extracellular Vesicles Derived from Breast Cancer Cells: Emerging Biomarkers of Tumor Progression and Metastasis

  2025cites this paper
• A hybrid deep learning model for mammographic breast cancer detection: Multi-autoencoder and attention mechanisms

  2025cites this paper
• Therapeutic potential of GNRHR analogs and SRC/FAK inhibitors to counteract tumor growth and metastasis in breast cancer.

  2025cites this paper
• Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study

  2025cites this paper
• Genetic Polymorphism of MDM2 Gene Associates with Breast Cancer Incidence in the Lower Northern Thailand.

  2025cites this paper
• Advanced machine learning framework for enhancing breast cancer diagnostics through transcriptomic profiling

  2025cites this paper
• Breast Cancer and Aging: Understanding the Complex Relationship and Implications for Prevention and Screening

  2025cites this paper
• Lymphovascular Invasion Detection in Breast Cancer Using Deep Learning

  2025cites this paper
• Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis

  2025cites this paper
• Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations

  2024cites this paper
• Heterogeneous Evolution of Breast Cancer Cells—An Endogenous Molecular-Cellular Network Study

  2024cites this paper
• "Lobular lesions of the breast: From the classic to the variants".

  2024cites this paper
• MiRNAs as potential biomarkers in early breast cancer detection: a systematic review

  2024cites this paper
• ANÁLISE DE GENES DIFERENCIALMENTE EXPRESSOS EM AMOSTRAS DE CÂNCER DE MAMA DO SEQUENCE READ ARCHIVE (SRA)

  2024cites this paper
• Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer

  2024cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

  2024cites this paper
• Expression of Axl Receptor Tyrosine Kinase and Its Association With Ki-67 Proliferation Marker, BCL-2 Anti-apoptotic Protein, Hormone Receptor Status, and HER2/Neu Status in Breast Cancer Among Women From Duhok, Iraq

  2024influential citation
• Breast cancer screening in women taking hormone replacement therapy needs updating

  2024cites this paper
• Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers

  2023cites this paper
• Incidence Rate and Clinical Characteristics of Triple Negative Breast Cancer Patients in Hasan Sadikin Hospital, for the Last Five Years

  2023cites this paper
• Glycosylation in breast cancer progression and mammary development: Molecular connections and malignant transformations.

  2023cites this paper
• Amygdalin may potentiate the effects of lapatinib on SK-BR-3 cancer cell death through increasing Bax expression

  2023cites this paper
• Multi-Disease Detection of Diabetes and Breast Cancer Using The Doctor Framework

  2023cites this paper
• Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?

  2023cites this paper
• High prevalence and dependence of centrosome clustering in mesenchymal tumors and leukemia

  2023cites this paper
• Augmenting breast cancer diagnosis: Incorporating MRI for the assessment of major molecular subtypes

  2023cites this paper
• Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine

  2023cites this paper
• Ductal Carcinoma in Situ: A Detailed Review of Current Practices

  2023influential citation
• Immuno-Histochemical Profile of Breast Cancers at the General Hospital of Douala-Cameroon

  2023cites this paper
• T-type Ca2+ channels and their relationship with pre-neoplastic and neoplastic lesions in the human breast

  2023cites this paper
• Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer

  2022cites this paper
• In situ single-cell analysis of canonical breast cancer biomarkers: phenotypic heterogeneity and implications on response to HER2 targeting agents

  2022cites this paper
• Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

  2022influential citation
• L-type voltage-dependent Ca2+ channels expression involved in pre-neoplastic transformation of breast cancer

  2022influential citation
• The Roles of the Fluorescent In Situ Hybridization (FISH) and Comparative Genomic Hybridization (CGH) Techniques in the Detection of the Breast Cancer

  2022cites this paper
• Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2

  2022cites this paper
• Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

  2022influential citation
• Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications.

  2022cites this paper
• Viscoelasticity, Like Forces, Plays a Role in Mechanotransduction

  2022cites this paper
• Intraductal Injections into the Mouse Mammary Gland.

  2022cites this paper
• CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer

  2022cites this paper
• Automatic breast carcinoma detection in histopathological micrographs based on Single Shot Multibox Detector

  2022cites this paper
• Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity

  2022cites this paper
• Invasive lobular carcinoma of the breast: the increasing importance of this special subtype

  2021cites this paper
• Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients

  2021cites this paper
• Effect of vitamin D3 on hyperplasia of mammary glands in experimental rats.

  2021cites this paper
• Viscoelasticity Acts as a Marker for Tumor Extracellular Matrix Characteristics

  2021cites this paper
• Osteopontin and breast cancer metastasis: possible role of genistein on the regulation of osteopontin

  2021cites this paper
• Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.

  2021cites this paper
• Changes in the Serum Concentrations of Essential Trace Metals in Patients with Benign and Malignant Breast Cancers

  2021cites this paper
• The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women

  2021cites this paper
• Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast

  2021cites this paper
• Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway

  2021cites this paper
• Relationship of ER, PR, HER2 / neu with Other Prognostic Factors in Breast Cancer along with the Role of Androgen Receptor in Triple Negative Breast Cancer

  2021cites this paper
• Colorimetric histology using plasmonically active microscope slides

  2021cites this paper
• Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ

  2021cites this paper
• Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules

  2021cites this paper
• The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer

  2020cites this paper
• Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?

  2020cites this paper
• Potential of Using Cell-Free DNA and miRNA in Breast Milk to Screen Early Breast Cancer

  2020cites this paper
• Ubiquitin-specific protease 7 downregulation suppresses breast cancer in vitro

  2020cites this paper
• Derivation of a nuclear heterogeneity image index to grade DCIS

  2020cites this paper
• Pitfalls and controversies in pathology impacting breast cancer management

  2020cites this paper
• Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations

  2020cites this paper
• Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target

  2020cites this paper
• Tumor size estimation of the breast cancer molecular subtypes using imaging techniques

  2020cites this paper
• Relationship Between Molecular Subtypes and Overall Survival of Breast Cancer in Bandung

  2020cites this paper
• Active Surveillance in the Management of Ductal Carcinoma in Situ: The Radiologist’s Point of View

  2020cites this paper
• Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer

  2020cites this paper
• Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231

  2019cites this paper
• Breast Cancer Pathology

  2019cites this paper
• Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26

  2019cites this paper
• Glycosylation and its implications in breast cancer

  2019cites this paper
• Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

  2019cites this paper
• Investigating stromal gene expression in metastatic and non-metastatic canine mammary tumours

  2019cites this paper
• Impact of hormonal status on ductal carcinoma in situ of the breast: Outcome and prognostic factors

  2019cites this paper
• Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors

  2019cites this paper
• OTT_A_214611 7749..7756

  2019cites this paper
• Lobular In Situ Neoplasia

  2019cites this paper
• Monitoring the progression of lobular breast carcinoma using multiphoton microscopy

  2019cites this paper
• Morphologic and Molecular Features of Breast Ductal Carcinoma in Situ.

  2019cites this paper
• Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort

  2019cites this paper
• Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment.

  2019cites this paper
• Intraductal Proliferative Disease of the Breast

  2019cites this paper
• Implications of nestin in breast cancer pathogenesis (Review).

  2018cites this paper
• Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision.

  2018cites this paper
• DCIS: Pathology and Biological Features

  2018cites this paper
• Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast

  2018cites this paper
• Ductal Carcinoma in Situ of the Breast

  2018cites this paper
• Distribution analysis of epertinib in brain metastasis of HER2-positive breast cancer by imaging mass spectrometry and prospect for antitumor activity

  2018cites this paper
• High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.

  2018cites this paper
• Evaluation of human epidermal growth factor receptor-2 and hormonal receptor expression patterns in breast cancer from fine needle aspiration cytology

  2018cites this paper
• Lésions frontières en pathologie mammaire à fort risque de surdiagnostic : lesquelles ? Double lecture anatomopathologique, une nécessité ?

  2018cites this paper
• Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy

  2018cites this paper
• "New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”

  2018influential citation
• Flat epithelial atypia: conservative management of patients without residual microcalcifications post-vacuum-assisted breast biopsy.

  2018cites this paper
• Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology

  2018cites this paper
• The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors?

  2018cites this paper
• CKS1BP7, a Pseudogene of CKS1B, is Co-Amplified with IGF1R in Breast Cancers

  2018cites this paper